$AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$17.11
▲+0.38%+$0.065
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAmneal Pharmaceuticals, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AMRX up today? It is at $17.11 (+0.38%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AMRX spikes, and full due diligence on AMRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AMRX 43 times in the last 30 days. Create a free account to track $AMRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
AMRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on AMRX today, peaking at 20.2x its normal volume.
Likely catalystAmneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader, from an SEC filing. Read it →Latest filingS-3ASRFiling (S-3ASR)Sep 3, 2026 · 5 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Boyer Andrew S Officer | Sold (automatic/other) | -80K 0.03% of company | sold 29% | 194K | n/a | Sep 1, 26 |
Boyer Andrew S Officer | Sold (automatic/other) | -152K 0.05% of company | sold 36% | 274K | n/a | Aug 21, 26 |
Kiely John Director | Sold (automatic/other) | -50K 0.02% of company | sold 19% | 210K | $882K at $17.64 | Aug 13, 26 |
Kiely John Director | Sold (automatic/other) | -10K | sold 4.8% | 200K | n/a | Aug 13, 26 |
Daly Jason B. Officer | Sold (automatic/other) | -210K 0.07% of company | sold 86% | 35K | $3.7M at $17.40 | Aug 12, 26 |
Shah Nikita Officer | Sold (automatic/other) | -146K 0.05% of company | sold 37% | 253K | $2.6M at $17.51 | Aug 12, 26 |
Buchi J Kevin Director | Other | 169K 0.05% of company | n/a | 93K | $2.9M at $17.18 | Aug 11, 26 |
Daly Jason B. Officer | Sold (automatic/other) | -7K | sold 2.6% | 245K | $117K at $17.70 | Aug 11, 26 |
Patel Chirag K. Officer | Acquired (grant/award) | +6.38M 2.0% of company | added 30% | 27.65M | n/a | Aug 10, 26 |
Patel Gautam Director | Acquired (grant/award) | +284K 0.09% of company | n/a | 284K | n/a | Aug 10, 26 |
Patel Chintu Officer | Acquired (grant/award) | +6.38M 2.0% of company | added 26% | 31.13M | n/a | Aug 10, 26 |
Patel Tushar Bhikhubhai Beneficial Owner (10%) | Acquired (grant/award) | +12.76M 4.0% of company | added 26% | 61.34M | n/a | Aug 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
AMRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on AMRX today, peaking at 20.2x its normal volume.
AMRX last traded at $17.11, up 0.38% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is next expected to report earnings on Thursday, October 29, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AMRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AMRX 43 times in the last 30 days.
AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $5.44B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AMRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AMRX discussion
Sign in to ask a question or join the discussion.